Anti-MUC1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in vivo Ovarian Cancer Model

Published 2011 View Full Article

Authors

Keywords

Ascites, Cancer treatment, Mouse models, Apoptosis, Toxicity, Animal models, Hematoxylin staining, Ovarian cancer

Journal

PLoS One

Volume 6, Issue 9, Pages e24405

Publisher

Public Library of Science (PLoS)

Online

2011-09-10

DOI

10.1371/journal.pone.0024405

References

View 10 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.